With over 16 years of experience, Concord Medical Services sets the highest standard of patient care, with our advanced technology and quality service across our extensive network of clinics and hospitals.
The most extensive medical service network
CCM owns and operates the largest network of medical facilities in China, leading the industry in revenue, patient volume, number of medical staff and academic publications. We are currently in the process of building the world’s largest statistical database for cancer diagnosis and treatment.
International and local medical expert team
We have relationships with international oncology hospitals and cancer institutions in the USA, Japan and Southeast Asia to further the sharing of best practices and new ideas. Our “CCM Medical Experts Committee” is comprised of thought leaders from China and around the world who serve as consultants to support our clinical consultation, academic research and medical training. We provide continuing education and training opportunities for all of our physicians, many of whom have been recognized as medical experts in their local communities.
Cooperating with MD Anderson Cancer Center
We have signed a strategic consulting agreement with The University of Texas MD Anderson Cancer Center. MD Anderson will be a strategy consultant for the Shanghai and Beijing cancer hospital projects we are planning. MD Anderson will provide the clinical and technical support in cancer specialized hospital and provide a full range of consulting services in cancer hospital market orientation, the overall design, the department set-up, medical procedures, and personnel training. In construction phase, we will work with China local famous cancer hospital to research some specific high-risk cancer in China.
Guided and supported by top international and domestic strategic investment institutions
Our top shareholders, China International Capital Corporation(CICC) and the Carlyle Group, not only provide financial support but also advise us on China’s latest healthcare policies and guide our growth strategy for the future.
Comprehensive corporate governance structure
As a public company listed on the New York Stock Exchange (NYSE: CCM), CCM maintains strict standards of corporate governance to ensure integrity and transparency across our operations.
Perfecting the quality control and management system
CCM is continually working to improve quality control and management practices to ensure safe and effective patient care. We are in the process of publishing standardized clinical guidelines for all of our treatment areas. In the next 3 to 5 years, we will introduce a web-based quality control system and international-standard physicist consultation system in order to further improve quality standards throughout the CCM network.
Furthering the development of oncology in China
CCM established the Gamma Knife Committee as part of the Chinese Medical Association. We have published several reference books and articles on radiation oncology in Chinese, conduct academic forums and seminars, and actively sponsor clinical research, all of which have made a huge contribution on diagnostic imaging and radiation oncology in China.